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SUMMARY
In areas endemic for schistosomiasis, people can often be
in contact with contaminated water resulting in repeated
exposures to infective Schistosoma mansoni cercariae.
Using a murine model, repeated infections result in IL-10-
dependent CD4+ T-cell hyporesponsiveness in the skin-
draining lymph nodes (sdLN), which could be caused by
an abundance of eosinophils and connective tissue mast
cells at the skin infection site. Here, we show that whilst
the absence of eosinophils did not have a significant effect
on cytokine production, MHC-II+ cells were more numer-
ous in the dermal cell exudate population. Nevertheless,
the absence of dermal eosinophils did not lead to an
increase in the responsiveness of CD4+ T cells in the
sdLN, revealing that eosinophils in repeatedly exposed skin
did not impact on the development of CD4+ T-cell
hyporesponsiveness. On the other hand, the absence of
connective tissue mast cells led to a reduction in dermal
IL-10 and to an increase in the number of MHC-II+ cells
infiltrating the skin. There was also a small but signifi-
cant alleviation of hyporesponsiveness in the sdLN, sug-
gesting that mast cells may have a role in regulating
immune responses after repeated exposures of the skin to
S. mansoni cercariae.
Keywords CD4 T lymphocytes < cell, Eosinophil < cell,
Immune modulation < immunological terms, Mast cell <
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Abbreviations: 1x, single infection; 4x, repeated infections;
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DC, dendritic cells; DEC, dermal exudate cells; DTx,
diphtheria toxin,; i.p., Intraperitoneal; sdLN, skin-draining
lymph nodes; SSAP, soluble schistosomula antigen prepa-
ration
INTRODUCTION
Schistosomiasis is a debilitating parasitic disease affecting
approximately 230 million people worldwide caused by
Schistosoma helminths (1, 2). Infection occurs after expo-
sure of the skin to free-swimming cercariae (3), and in
areas that are endemic for this parasitic disease,
individuals can be exposed to cercariae on numerous occa-
sions during domestic activities, resulting in repeated infec-
tions. In this context, we developed a murine percutaneous
infection model which showed that repeated exposure (4x)
of the skin to infective Schistosoma mansoni cercariae
resulted in hyporesponsiveness of CD3+ CD4+ T cells
within the local skin-draining lymph nodes (sdLN) (4).
Significantly, this hyporesponsiveness was evident before
the onset of egg deposition, which is conventionally asso-
ciated with immune downregulation to chronic schisto-
some infection (5–11), and was dependent on the presence
of IL-10 without which CD4+ T cells in the sdLN were
fully responsive to antigen (12).
After repeated S. mansoni infection, IL-10 was predomi-
nantly produced by CD4+ T cells in both the sdLN (12) and
the skin (13), yet the signals that trigger IL-10 production
by CD4+ T cells in this setting remain unclear. The skin
infection site is the most likely cellular source of these IL-10
inducing signals as it undergoes substantial changes after
percutaneous exposure to infective cercariae including the
influx of different immune cells (e.g. dendritic cells (DC),
macrophages, eosinophils, neutrophils and CD3+ CD4+ T
cells) (13), the proliferation of nonhaematopoietic cells
Correspondence: Adrian P. Mountford, Centre for Immunology
and Infection, Department of Biology, University of York, York,
UK (e-mail: adrian.mountford@york.ac.uk).
†Present address: Institute of Infection, Immunity and Inflamma-
tion, University of Glasgow, Glasgow, UK
§Present address: Max-Planck Institute of Immunobiology and
Epigenetics, Stübeweg 51, 79108 Freiburg im Breisgau, Germany
Received: 28 August 2015
Accepted for publication: 7 December 2015
© 2015 The Authors. Parasite Immunology Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License,
which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
81
Parasite Immunology, 2016, 38, 81–92 DOI: 10.1111/pim.12300
(such as keratinocytes (4, 14)) and major changes in the der-
mal cytokine environment (4, 14). One of the most notice-
able effects in the skin of repeated schistosome infections is
that up to 80% of dermal exudate cells (DEC) comprise
SiglecF+ eosinophils (4). Eosinophils can have a significant
effect on conditioning the immune response to many infec-
tious diseases and in allergy (15, 16), and they have been
considered important in the context of tissue remodelling
and immune regulation (15, 17–20). In general, eosinophils
are thought to be host protective in defence against parasitic
helminths; however, evidence can be contradictory, perhaps
due to the numerous different methodologies available to
investigate eosinophil function (21–23). Connective tissue
mast cells, which differ from mucosal mast cells (24), are
also present in significantly increased numbers in the skin
after repeated schistosome infections (4). These cells are
known to influence the regulation of the immune response
by affecting antigen presentation, DC function and particu-
larly T-cell function (25). Therefore, we speculate that the
abundance of eosinophils or mast cells could condition
immune responses in the skin, and ultimately the develop-
ment of CD4+ hyporesponsiveness in the lymph nodes
draining the site of infection in mice exposed repeatedly to
infective S. mansoni cercariae.
Here, we show that the abundant eosinophil population of
DEC after repeated (4x) exposure to infective S. mansoni
cercariae was significantly reduced following ablation using
anti-CCR3 mAb and was absent in eosinophil-deficient
DdblGATA-1 mice. Somewhat surprisingly, however, despite
eosinophils comprising the majority of 4x DEC, their
absence did not have a major impact on the immune environ-
ment in the skin, or on the development of CD4+ T-cell
hyporesponsiveness in the sdLN. The role of connective tis-
sue mast cells following repeated infection was investigated
using mast cell-deficient Mctp5Cre iDTR mice (26, 27), and
we found that the absence of mast cells in the skin of 4x
infected mice resulted in a reduction in the production of
immunoregulatory IL-10 by in vitro cultured skin biopsies,
an increase in the number of MHC–II+ cells in the skin and
led to a small but significant increase in the proliferation of
cells recovered from the sdLN. This indicated that connective
tissue mast cells could have a contributory role in the devel-
opment of CD4+ T-cell hyporesponsiveness within the sdLN.
MATERIALS AND METHODS
Animals
Groups of C57BL/6 wild-type (WT) mice and mast cell
depletable Mcpt5cre iDTR mice (26) (obtained from Dr
Axel Roers, Institute for Immunology, Technische Univer-
sit€at Dresden, Germany) were bred and housed at the
University of York, York UK. DdblGATA-1 mice (devoid
of eosinophils) (28) were bred and housed at the University
of Manchester, Manchester, UK. For both groups of trans-
genic mice, heterozygous littermates were used as infection
controls. All experiments used age (6–10 weeks)- and sex-
matched animals carried out in accordance with the United
Kingdom Animals Scientific Procedures Act 1986, and with
approval of the University of York Ethics Committee, and/
or the University of Manchester Ethics Committee.
Parasites and infection protocol
Mice were percutaneously exposed via the pinnae to either
a single dose (1x) of 75–150 S. mansoni cercariae (29), or
to four doses (4x) 7 days apart (4). Given a 50% penetra-
tion rate to the pinna (4), the cumulative total infection
dose in 4x mice was ~300 parasites per mouse.
Eosinophil depletion by anti-CCR3 antibody
administration
Eosinophils were depleted from C57BL/6 mice with weekly
doses of 1 mg rat anti-CCR3 6S2-19-4 (30) monoclonal
antibody (mAb) in PBS via intraperitoneal (i.p.) injection.
The ablation regime started 1 week prior to the first infec-
tion with S. mansoni cercariae, and the final dose taking
place 24 h prior to the fourth infection. The anti-CCR3
6S2-19-4 hybridoma cell line was a gift from Professor
Judith Allen, Edinburgh University. The cell line was
grown in a CELLine CL 1000 flask (Integra Biosciences,
Zizers, Switzerland) and the mAb purified from the col-
lected culture supernatant using an €AKTA Prime.
Mast cell depletion
Mcpt5Cre+ iDTR+ and Mcpt5Cre control mice received
25 ng/g diphtheria toxin (DTx, Sigma-Aldrich, Dorset,
UK) i.p. at weekly intervals for 4 weeks. Both groups of
mice were then exposed to S. mansoni cercariae via the pin-
nae (as described above). During the infection time course,
mice were also treated with 25 ng/g DTx i.p. at 7-day inter-
vals (1 day prior to infection), as well as DTx at the base
of the ear subcutaneously (s.c.) at 5 ng/g (on the day of
infection). Tissue sections of OCT embedded pinnae were
stained with toluidine blue to determine the extent of mast
cell depletion (Department of Veterinary Pathology,
University of Liverpool).
Recovery of dermal exudate cells (DEC)
Pinnae of mice were harvested 4 days after the final
infection, split along central cartilage and floated on top
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of RPMI-1640 (Gibco, Paisley, UK) containing 10%
heat-inactivated foetal calf serum (FCS) (Biosera, Uck-
field, UK), 2 mM L-glutamine, 1% Pen/Strep (both
Gibco) and 50 lM 2-mercaptoethanol (Sigma-Aldrich)
(complete RPMI) in nonadherent 24-well tissue culture
plates (Greiner Labortechnik, Frickenhausen, Germany)
as previously described (4,29). After an overnight culture
in vitro at 37°C 5% CO2, DEC were recovered from the
culture supernatant following centrifugation at 1000 g for
7 min at 4°C and resuspended in fresh complete RPMI.
Cell-free culture supernatants from the skin biopsies were
stored at 20°C before analysis by cytokine-specific
ELISA.
In vitro culture of total sdLN cells
Pairs of sdLN (auricular lymph nodes, draining the pinnae)
were removed from mice 4 days after the final infection
and were processed to a single-cell suspension prior to cul-
ture at 1 9 106 cells/mL in complete RPMI in the pres-
ence, or absence, of 50 lg/mL soluble schistosomula
antigen preparation (SSAP) (31) for 72 h at 37°C. In vitro
proliferation of sdLN cells was assessed through the
decrease of carboxyfluorescein diacetate succinimidyl ester
(CFSE) (Life Technologies, Paisley, UK) stain (4, 32).
Briefly, sdLN cells were labelled with 3 lM CFSE prior to
in vitro culture with parasite antigen. After 96 h of culture,
sdLN cells were labelled with a fixable live/dead marker
(Life Technologies) and then with fluorescently labelled
anti-CD3 and anti-CD4 mAbs (eBioscience, Hatfield,
UK); cell proliferation was measured as a decline in CFSE
in the labelled cells determined by flow cytometry. Alterna-
tively, proliferation was measured via incorporation of [3H]
thymidine (185 kBq per well, PerkinElmer, Coventry, UK)
by sdLN cells cultured in vitro with SSAP antigen as
described previously (4, 32). Comparable results with
regard to CD4+ T-cell proliferation in the sdLN have been
obtained previously with CFSE and [3H]thymidine incor-
poration (4, 12).
Cytokine analysis by ELISA
Supernatants from skin biopsy cultures were collected for
cytokine analysis as previously described (33). Cytokines
IL-4, IL-10 and IL-12p40 were quantified using the
DuoSet ELISA kits (R&D Systems, Abingdon, UK).
Flow cytometry
Cells were washed in ice-cold PBS and labelled with
LIVE/DEAD Fixable Aqua Dead Cell Stain (Life Tech-
nologies) according to the manufacturer’s instructions.
Cell aliquots were then washed in buffer (PBS containing
1% FCS), incubated with 1 lg anti-CD16/32 mAb (eBio-
science) in goat serum (Sigma-Aldrich) and subsequently
labelled with the following mAb conjugated to various flu-
orochromes: anti-CD45 (clone 2D1), anti-CD11b (clone
M1/70), anti-MHC-II (IA-IE) (clone M5/114), anti-F4/80
(clone BM8), anti-SiglecF (clone eBio440c), anti-CD4
(clone RM4-5) and anti-CD3 (clone 17A2) (all eBio-
science). Results were acquired on either a Cyan ADP
analyser (DakoCytomation, Ely, UK), or a BD LSR
Fortessa analyser (BD Biosciences, Oxford, UK). Data
were analysed using FLOWJO software v7.6.5 (Tree Star Inc,
Oregon Bio, Ashland, OR, USA).
Statistics
Statistical analyses were performed using the Student’s
t-test or one-way analysis of variance (ANOVA) test. Data
on graphs are shown as mean  SEM. Level of statistical
significance is indicated in each figure. Statistical
analyses and presentation of data were performed using
GRAPHPAD PRISM 6 (GraphPad, Software Inc, San Diego,
CA, USA).
RESULTS
Repeated infections (4x) of the skin with S. mansoni cer-
cariae compared to a single infection (1x) resulted in an
increased number of DEC recovered from in vitro cultured
biopsies of the skin infection site (Fig. 1a). Based on the
expression of F4/80 and MHC-II, the recovered DEC popu-
lation contained a mixture of cell types; the F4/80 MHC-
II population (denoted ‘R1’) comprised cells which had
previously been defined by our group as CD11b+ neu-
trophils and CD3+ CD4+ T cells (13), whilst the F4/80+
MHC-II population (denoted ‘R2’) comprised eosinophils
(Fig. 1b; ‘R2’ cell population is highlighted with circles in
bold) previously shown to be SiglecF+ (4). The remaining
cells were classed as macrophages or DCs based upon their
differing expression levels of MHC-II and F4/80 (13, 34).
Cells which were F4/80+ MHC-IIint (denoted ‘R3’) were
classified as macrophages, F4/80 MHC-IIhi cells (denoted
‘R4’) were classed as infiltrating DCs, whilst F4/80+ MHC-
IIhi cells (denoted ‘R4A’) were regarded as tissue-resident
macrophages (Fig. 1b). After 1x infection, the F4/80+
MHC-II eosinophil population (R2) comprised approxi-
mately 20% of the CD45+ DEC population, whilst in 4x
mice, there was a significant increase to ~40% of CD45+
DEC and eosinophils constituted the most abundant DEC
population (Fig. 1b–d; P < 001).
To determine whether the abundance of eosinophils in
the skin of 4x mice has an effect on the immune response
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at the site of infection and in the sdLN, anti-CCR3 mAb
was used to deplete eosinophils in vivo. Both the propor-
tion (Fig. 2a) and number (Fig. 2b) of eosinophils in the
DEC population were significantly reduced in 1x and 4x
infected mice following anti-CCR3 mAb treatment. How-
ever, cytokine production by in vitro cultured skin biopsies
showed that the reduction in eosinophilia following
anti-CCR3 mAb treatment had no effect on the levels of
IL-12p40 and IL-4 (Fig. 2c,d; P > 005), whilst there was
a significant increase in IL-10 only in 1x mice (Fig. 2e; 1x
mice, P < 005; 4x mice, P > 005).
Eosinophil ablation by anti-CCR3 mAb treatment
revealed that there was a trend to increased numbers of
both ‘R3’ F4/80+ MHC-IIint macrophages, and ‘R4A’ F4/
80+ MHC-IIhi tissue-resident macrophages in the DEC
population obtained from 4x mice, although this was not
significant (Fig. 3a,b; P > 005). There was, however, an
increase in the number of ‘R4’ F4/80 MHC-IIhi infiltrat-
ing DCs in mAb-treated 4x mice (Fig. 3c; P < 005).
As depletion of eosinophils in the skin after anti-CCR3
mAb treatment was not absolute (Fig. 2a,b), immune
responses were also examined in transgenic eosinophil-
deficient DdblGATA-1 mice. Littermate GATA-1-sufficient
control mice exhibited significant increases in the propor-
tions and numbers of SiglecF+ eosinophils in 4x compared
with 1x infected mice (Fig. 4a–c; P < 0001). In contrast,
eosinophils were absent in the DdblGATA-1 mice after 1x
and after 4x infections (Fig. 4a–c; P < 0001). Analysis of
cytokine production by in vitro cultured skin biopsies
showed that whilst both IL-4 and IL-10 were significantly
increased in 4x compared to 1x skin samples (Fig. 4e,f),
there were no significant differences in the levels of IL-4,
IL-10 or IL-12p40, between those obtained from GATA-1
control and DdblGATA-1 mice (Fig. 4d–f).
The numbers of ‘R3’ (F4/80+ MHC-IIint) macrophages
and R4A (F4/80+ MHC-IIhi) tissue-resident macrophages
recovered from 4x infected GATA-1 control and
DdblGATA-1 mice were not significantly different
(Fig. 5a–c; P > 005), although the numbers of R4 (F4/
80 MHC-IIhi) infiltrating DCs increased in 4x eosino-
phil-deficient DdblGATA-1 mice (Fig. 5d; P < 001).
Therefore, the absence of the eosinophils appears to alter
Figure 1 Eosinophils represent a significant proportion of the DEC population after repeated infections of the skin with S. mansoni
cercariae. (a) Total number of DEC recovered from skin biopsies after 1x and 4x infection of C57BL/6 mice. (b) Representative flow
cytometry dot plots of DEC previously gated on live cells, singlets and CD45+ cells showing expression of F4/80 and MHC-II on DEC for
1x and 4x infected mice. Gating strategy is shown for ‘R1’ F4/80MHC-II, ‘R2’ F4/80+MHC-IIeosinophils, ‘R3’ F4/80+MHC-IIint
macrophages, ‘R4’ F4/80MHC-IIhi infiltrating DCs and ‘R4A’ F4/80+MHC-IIhi tissue-resident macrophages. Circles in bold highlight the
‘R2’ F4/80+ MHC-II eosinophil population. (c) Proportion and (d) number of F4/80+ MHC-II eosinophils in DEC after 1x and 4x
infection. Symbols are values for individual mice within a single experiment, and horizontal bars are means  SEM (n = 5 mice);
** denotes P ≤ 001, *** P ≤ 0001 (Student’s t-test). Data are representative of four separate infection experiments.
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Figure 2 Administration of anti-CCR3 mAb reduces eosinophilia in the skin. (a) Percentage, and (b) absolute number of eosinophils in
DEC populations in 1x and 4x infected mice after anti-CCR3 mAb treatment. Symbols are values for individual mice, and horizontal bars
are means SEM (n = 6 mice); **P ≤ 001, *** P ≤ 0001. Levels of (c) IL-12p40, (d) IL-4 and (e) IL-10 released from in vitro cultured
skin biopsies obtained from 1x and 4x infected mice. Bars represent mean + SEM; *P ≤ 005, n.s. = P > 005 (one-way ANOVA). Data are
representative of three separate experiments.
Figure 3 Depletion of eosinophils following
administration of anti-CCR3 mAb increases
the number of infiltrating DCs. Numbers of
(a) ‘R3’, F4/80+MHC-IIint macrophages, (b)
‘R4A’ F4/80+MHC-IIhi tissue-resident
macrophages and (c) ‘R4’ F4/80MHC-IIhi
infiltrating DCs in DEC recovered from 1x
or 4x mice after treatments with anti-CCR3
mAb. Symbols are values for individual
mice, and horizontal bars are means  SEM
(n = 5–6 mice); *P ≤ 005, where no value is
given comparisons were not significant;
P > 005 (one-way ANOVA). Data are
representative of 3 separate experiments.
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the number of infiltrating F4/80 MHC-IIhi DCs but not
F4/80+ MHC-II+ macrophages in the skin after repeated
exposures to infective cercariae.
The increase in the number of infiltrating MHC-IIhi DC
in the skin infection site in the absence of eosinophils
(following anti-CCR3 mAb treatment, and in eosinophil-
deficient DdblGATA-1 mice) could enhance downstream
antigen presentation to na€ıve T cells and therefore increase
the responsiveness of CD4+ T cells in the sdLN. However,
in response to in vitro re-stimulation with parasite antigen,
proliferation of CD4+ T cells from anti-CCR3-treated 4x
infected mice was low and was comparable to proliferation
Figure 4 The absence of eosinophils in DdblGATA-1 mice does not alter the production of IL-12, IL-4 or IL-10 in the skin infection site.
(a) Representative flow cytometry dot plots of DEC labelled with anti-SiglecF+ to label eosinophil populations in 1x and 4x infected
GATA-1 control (top) and DdblGATA-1 eosinophil-deficient mice (bottom); gate denotes SiglecF+ cells. (b) Proportion and, (c) absolute
number of SiglecF+ eosinophils in infected GATA-1 control and DdblGATA-1 eosinophil-deficient mice. Symbols are values for individual
mice; horizontal bars are means  SEM (n = 3–5 mice). Production of (d) IL-12p40, (e) IL-4 and (f) IL-10 by in vitro cultured skin
biopsies from 1x and 4x infected mice. Error bars represent mean + SEM; *P ≤ 005, ***P ≤ 0001, n.s. = P > 005 (one-way ANOVA).
86 © 2015 The Authors. Parasite Immunology Published by John Wiley & Sons Ltd., Parasite Immunology, 38, 81–92
C. T. Prendergast et al. Parasite Immunology
Figure 5 The absence of eosinophils in DdblGATA-1 mice causes an increase in infiltrating DCs in the skin infection site of 4x mice. (a)
Representative flow cytometry dot plots of cells previously gated on live cells and singlets, showing F4/80 and MHC-II expression in DEC
populations from 1x and 4x infected GATA-1 control and DdblGATA-1 eosinophil-deficient mice. Numbers of (b) ‘R3’ (F4/80+MHC-IIint)
macrophages, (c) ‘R4A’ (F4/80+MHC-IIhi) tissue-resident macrophages and (d) ‘R4’ (F4/80MHC-IIhi) infiltrating DCs in 1x and 4x
infected mice. Symbols are values for individual mice, and horizontal bars are means  SEM (n = 3–5 mice); **P ≤ 001, n.s. = P > 005
(one-way ANOVA).
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from 4x infected PBS-treated mice (Fig. 6a; P > 005). In
fact, levels of CD4+ T-cell proliferation in both groups of
4x infected mice were significantly lower than in 1x
infected mice (Fig. 6a; P < 0001). Low levels of CD4+ T-
cell proliferation were also observed in 4x eosinophil-defi-
cient DdblGATA-1 mice, which were the same as the low
levels in 4x GATA-1 control mice (Fig. 6b) showing that
the absence of eosinophils did not alleviate CD4+ T-cell
hyporesponsiveness.
A possible role of connective tissue mast cells in condi-
tioning the dermal immune environment was investigated
in Mcpt5-Cre+ iDTR+ mice (27, 35) depleted of mast cells
from the skin through the administration of successive
doses of diphtheria toxin (DTx). Near total ablation of
mast cells as assessed by staining of skin sections with
toluidine blue was achieved with four doses of DTx,
(Fig. S1a,b), although a note of caution is required as
degranulated mast cells would likely not be identified
using this technique and could act as a potential source of
immunological mediators. In the absence of mast cells, the
production of IL-12p40 and IL-4 from 4x skin biopsies
was unaffected compared to Mcpt5-Cre control mice
(Fig. 7a,b; both P > 005), although the production of
regulatory IL-10 by 4x infected Mcpt5-Cre+ iDTR+ mice
was significantly reduced, suggesting mast cells affect
secretion of this cytokine (Fig. 7c, P < 0001). Analysis of
the DEC populations recovered from the skin infection
site of 4x infected mice showed that there was an increase
in the number of ‘R2’ F4/80+ MHC-II eosinophils in
Mcpt5-Cre+ compared to Mcpt5-Cre control mice
(Fig. 7d, P < 0001). There were also increases in the num-
bers of ‘R3’ F4/80+ MHC-IIint macrophages (Fig. 7e;
P < 001) and ‘R4’ F4/80 MHC-IIhi infiltrating DCs
(Fig. 7g; P < 005), although the apparent increase in F4/
80+ MHC-IIhi tissue-resident macrophages was not signifi-
cant (Fig. 7f; P > 005).
Finally, there was no significant difference in the levels
of in vitro SSAP-specific proliferation of sdLN cells recov-
ered from 1x infected mast cell-depleted Mcpt5-Cre+ com-
pared to 1x infected control Mcpt5-Cre mice (Fig. 8;
P > 005). In contrast, the absence of mast cells in 4x
infected mice resulted in a small but significant increase in
cell proliferation compared to 4x infected control mice
(Fig. 8; P < 005). This suggests that mast cells may have
a limited role in regulating the inflammatory immune
response as their absence results in a partial alleviation of
the T-cell hyporesponsiveness observed in the sdLN.
DISCUSSION
This study aimed to investigate the role of eosinophils and
connective tissue mast cells in the early dermal immune
response in a murine model of repeated exposures to infec-
tive S. mansoni cercariae. Both types of cells are abundant
after multiple infections, and their presence may be critical
to conditioning the local immune response, particularly
the development of CD4 T-cell hyporesponsiveness, which
is a hallmark of repeated exposure to schistosome cer-
cariae (4). The data presented here show that eosinophils
do not have a major effect in conditioning the immune
response after 4x infection. On the other hand, the
absence of connective tissue mast cells was showed to alle-
viate CD4 T-cell hyporesponsiveness, possibly by causing
reduced production of IL-10 in the skin.
Figure 6 The absence of eosinophils does not alleviate CD4 T-cell hyporesponsiveness in the sdLN of 4x infected mice. (a) Proportion of
CFSEdim CD3+ CD4+ T cells in 1x and 4x infected mice and 4x infected mice treated with anti-CCR3 mAb, after in vitro stimulation with
50 lg/mL SSAP. CFSEdim CD3+ CD4+ T cells are those that have undergone at least one round of proliferation. (b) Proportion of
CFSEdim CD3+ CD4+ T cells from 1x or 4x GATA-1 control or DdblGATA-1 eosinophil-deficient mice, after in vitro culture with 50 lg/
mL SSAP. Symbols are values for individual mice, and horizontal bars are means  SEM (n = 3–6 mice); **P ≤ 001, ***P ≤ 0001,
n.s. = P > 005 (one-way ANOVA). Data are representative of 1–3 separate infection experiments.
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Eosinophils are known to be elevated in allergy and
in response to helminth infection, although their precise
role is still being established (17, 36). Indeed, the
absence of eosinophils adversely affects the survival of
Trichinella spiralis helminth larvae, suggesting that they
can be protective towards parasite infection (37). Previ-
ously we reported that the large influx of eosinophils
into the skin infection site could be blocked by injection
with rIL-12, which also restored responsiveness of CD4+
T cells in the sdLN (4). We therefore hypothesized that
eosinophils may indirectly condition the local immune
response in the skin leading to CD4+ T-cell hyporespon-
siveness and examined this through direct ablation fol-
lowing administration of anti-CCR3 mAb and in
DdblGATA-1 mice. We showed that there was no differ-
ence in the production of IL-4, IL-12p40 and IL-10 in
the skin of 4x infected mice using either strategy,
although anti-CCR3 mAb treatment did not yield com-
plete eosinophil ablation leaving a small number of
remaining cells which could be sufficient to negate any
differences in cytokine production. This supports previ-
ous studies that found no difference in serum IL-4 pro-
Figure 7 The absence of mast cells in the
skin alters production of IL-10 and increases
the number of MHC-II+ cells in the skin.
Production of (a) IL-12p40, (b) IL-4 and (c)
IL-10, by in vitro cultured skin biopsies
obtained from 1x and 4x infected Mcpt5Cre
control and mast cell-depleted mice.
Numbers of (d) ‘R2’ (F4/80+MHC-II)
eosinophils, (e) ‘R3’ (F4/80+MHC-IIint)
macrophages, (f), ‘R4A’ (F4/80+MHC-IIhi)
tissue-resident macrophages and (g) ‘R4’
(F4/80MHC-IIhi) infiltrating DCs in 1x and
4x infected mice. Symbols are values for
individual mice, and horizontal bars are
means  SEM (n = 3–6 mice); *P ≤ 005,
**P ≤ 001, ***P ≤ 0001, n.s. = P > 005
(one-way ANOVA).
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duction between S. mansoni-infected WT and
DdblGATA-1 mice (22).
Eosinophils can produce IL-10 (15), which is critical for
T-cell hyporesponsiveness in our model (12), and it has
been reported that IL-10 derived from eosinophils facili-
tates survival of the helminth parasite T. spiralis (38). So,
it is perhaps surprising that we did not detect a significant
reduction in IL-10 cytokine production in the absence of
eosinophils. However, we recently showed that in 4x schis-
tosome-infected mice, the majority of IL-10+ cells in the
skin were of lymphoid, rather than myeloid, origin (13).
Thus, eosinophils are not a source of regulatory IL-10 in
our model despite their abundance.
The absence of eosinophils resulted in a significant
increase in the numbers of infiltrating MHC-IIhi DCs.
This is counter to the view of others that the absence of
eosinophils decreases the recruitment of DCs (38, 39), as
eosinophil-derived neurotoxin (EDN) acts as a DC
chemoattractant in vitro and in vivo (40). The increase in
the number of MHC-IIhi DCs and their subsequent
migration to the sdLN might be expected to result in
enhanced CD4+ cell proliferation. However, the absence
of eosinophils did not increase CD4+ cell responsiveness
in the sdLN of 4x mice. On the other hand, as it is
known that eosinophils can act directly as antigen-pre-
senting cells after infection with the helminth Strongy-
loides (41–43), it is possible that eosinophils aid priming
CD4+ cell responses. Indeed, in 1x schistosome-infected
DdblGATA-1 mice, the CD4+ T-cell response in the
sdLN was lower than in GATA-1 control mice, indicat-
ing that after a single exposure to cercariae eosinophils
might be acting by an undefined mechanism (e.g. antigen
presentation, or cytokine production) to promote the ini-
tial immune response. Nevertheless, this reduction was
not observed after anti-CCR3 mAb was administered to
1x infected mice. Moreover, CD4+ T cells in the sdLN
remained hyporesponsive in 4x infected DdblGATA-1
mice. This supports earlier studies where anti-IL-5 mAb
used to ablate eosinophils at the chronic stage of S. man-
soni infection had no effect on the cellular immune
response (44). Schistosome infection of eosinophil-defi-
cient DdblGATA-1 and TgPHIL mice also had no effect
on the disease process (22), although another study
observed that infected DdblGATA-1 mice had reduced
Th2 response to S. mansoni eggs in terms of IL-4 pro-
duction (45).
As mast cells have the potential to impact on the
development of acquired immune responses (24, 25), it
was thought possible that connective tissue mast cells
play a role in the development of CD4+ T-cell hypore-
sponsiveness in our model, although in a recent report
mast cells had no impact on the development of skin
localized immune responses to Leishmania major (46).
Here, we found that using schistosome-infected Mcp-
t5Cre iDTR mice, there was an increase in the number
MHC-II+ cells in the absence of mast cells, supporting
the notion that mast cells regulate cell populations with
antigen-presenting function (47). This could be related
to the decrease in the amount of IL-10 released in the
skin of 4x Mcpt5-Cre+ iDTR+ mast cell-deficient mice
leading to enhanced presentation of parasite antigen to
CD4+ T cells in the sdLN. Therefore, as CD4+ hypore-
sponsiveness in the sdLN of 4x mice in our infection
model is IL-10 dependent (12), and the partial recovery
in CD4+ T-cell responsiveness in the 4x infected Mcp-
t5Cre iDTR mice was accompanied by a loss in the
production of IL-10, we propose mast cells contribute
signals to condition dermal CD4+ T cells in the skin to
produce further IL-10.
In conclusion, whilst significantly increased numbers of
eosinophils were observed in the skin after repeated expo-
sure to S. mansoni cercariae, the absence of eosinophils
had no bearing on CD4+ T-cell responses in the down-
stream sdLN. Conversely, the absence of connective tissue
mast cells led to decreased IL-10 production and increased
numbers of MHC-II+ cells in the skin which promotes
responsiveness of cells in the sdLN. Therefore, we suggest
that connective tissue mast cells condition the skin cyto-
kine environment, which dampens and downregulates
CD4+ T-cell responses in the sdLN leading to hyporespon-
siveness.
Figure 8 The absence of connective tissue mast cells in the skin
leads to a slight increase in sdLN cell responsiveness. Proliferation
of in vitro cultured sdLN cells stimulated with SSAP in 1x and 4x
infected Mcpt5Cre+iDTR+ mast cell-depleted and Mcpt5Cre
control mice, as measured by [3H]thymidine incorporation. Error
bars represent mean  SEM; n = 4 mice per group, *P ≤ 005
(one-way ANOVA). Data are representative of two separate
infection experiments.
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may be found in the online version
of this article:
Figure S1. Depletion of mast cells
using Mcpt5Cre+iDTR+ mice
requires the administration of four
doses of DTx. (a) Representative
images of Toluidine Blue stained sec-
tions of na€ıve ear pinnae to visualize
mast cells after no DTx treatment
(left), 1x DTx (middle) or 4x weekly
DTx (right) treatment. Arrows repre-
sent mast cells. (b) Quantitative anal-
ysis of mast cell depletion following
administration of DTx in either con-
trol (Mcpt5CreiDTR), or mast cell
depletable (Mcpt5Cre+iDTR+) mice
as determined by the number of mast
cells in the field of view (F.O.V.) per
pinnae section. Scale bar represents
01 mm. Symbols are values for indi-
vidual mice, horizontal bars are
means  SEM (n = 4–7 mice);
***P ≤ 0001, n.s. = P > 005 (one-
way ANOVA).
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